1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane has been researched along with pentobarbital in 1 studies
| Studies (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Trials (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Recent Studies (post-2010) (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Studies (pentobarbital) | Trials (pentobarbital) | Recent Studies (post-2010) (pentobarbital) |
|---|---|---|---|---|---|
| 40 | 0 | 5 | 10,272 | 175 | 439 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korpi, ER; Maksay, G; Uusi-Oukari, M | 1 |
1 other study(ies) available for 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane and pentobarbital
| Article | Year |
|---|---|
Bimodal action of furosemide on convulsant [3H]EBOB binding to cerebellar and cortical GABA(A) receptors.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cerebellum; Cerebral Cortex; Chlorides; Convulsants; Furosemide; GABA Modulators; gamma-Aminobutyric Acid; Kinetics; Niflumic Acid; Pentobarbital; Rats; Rats, Wistar; Receptors, GABA-A | 1998 |